STOCK TITAN

Analog Devices (NASDAQ: ADI) CEO sells 10K shares under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Analog Devices Chair & CEO Vincent Roche exercised stock options and sold shares in a planned transaction. On May 1, 2026, he exercised 10,000 non-qualified stock options for common stock at $94.41 per share and received 10,000 shares of Analog Devices common stock.

The same day, he sold 10,000 common shares in an open-market transaction at an average price of $397.91 per share, pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, Roche holds about 187,537.875 shares directly and 23,515 shares indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust.

Positive

  • None.

Negative

  • None.
Insider ROCHE VINCENT
Role Chair & CEO
Sold 10,000 shs ($3.98M)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 10,000 $94.41 $944K
Exercise Comm Stock - $.16-2/3 value 10,000 $94.41 $944K
Sale Comm Stock - $.16-2/3 value 10,000 $397.91 $3.98M
holding Comm Stock-$.16-2/3 value -- -- --
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 14,637 shares (Direct, null); Comm Stock - $.16-2/3 value — 197,537.875 shares (Direct, null); Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust)
Footnotes (1)
  1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on May 23, 2025. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. This option is fully vested.
Shares sold 10,000 shares Open-market sale of common stock on May 1, 2026
Sale price per share $397.91 per share Average price for 10,000 common shares sold
Option exercise price $94.41 per share Non-qualified stock options exercised for 10,000 shares
Direct holdings after transactions 187,537.875 shares Common stock directly owned by Roche after May 1, 2026
Indirect trust holdings 23,515 shares Shares held by Vincent Roche 2024 Grantor Retained Annuity Trust
Net share change from buy/sell -10,000 shares Net of open-market sale relative to exercises and other trades
Rule 10b5-1 trading plan regulatory
"These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Grantor Retained Annuity Trust financial
"Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ROCHE VINCENT

(Last)(First)(Middle)
ONE ANALOG WAY

(Street)
WILMINGTON MASSACHUSETTS 01887

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ANALOG DEVICES INC [ ADI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chair & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Comm Stock - $.16-2/3 value05/01/2026M10,000A$94.41197,537.875D
Comm Stock - $.16-2/3 value05/01/2026S10,000(1)D$397.91187,537.875D
Comm Stock-$.16-2/3 value23,515I(2)Vincent Roche 2024 Grantor Retained Annuity Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$94.4105/01/2026M10,000 (3)03/11/2030Comm Stock - $.16-2/3 value10,000$94.4114,637D
Explanation of Responses:
1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on May 23, 2025.
2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
3. This option is fully vested.
Remarks:
/s/ Shelly Shaw, General Counsel, by Power of Attorney05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did ADI CEO Vincent Roche report on this Form 4?

Vincent Roche reported exercising 10,000 non-qualified stock options at $94.41 per share, then selling 10,000 Analog Devices common shares at $397.91 per share, both dated May 1, 2026, leaving him with substantial remaining direct and indirect holdings.

How many Analog Devices (ADI) shares did the CEO sell and at what price?

Roche sold 10,000 Analog Devices common shares in an open-market transaction at an average price of $397.91 per share. This sale occurred on May 1, 2026 and was executed under a pre-arranged Rule 10b5-1 trading plan adopted in May 2025.

What options did the ADI CEO exercise in this Form 4 filing?

He exercised 10,000 non-qualified stock options with a $94.41 per share exercise price, converting them into 10,000 shares of Analog Devices common stock. The filing notes this option grant is fully vested, and the exercise occurred on May 1, 2026.

Were the ADI CEO’s share sales made under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes state the 10,000 Analog Devices shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Vincent Roche on May 23, 2025. Such pre-arranged plans typically schedule trades in advance to support routine portfolio management.

How many Analog Devices (ADI) shares does the CEO hold after these transactions?

Following the May 1, 2026 transactions, Roche holds about 187,537.875 Analog Devices shares directly. He also indirectly holds 23,515 shares through the Vincent Roche 2024 Grantor Retained Annuity Trust, as disclosed in the Form 4 holding entry.

What is the nature of the ADI shares held indirectly by the CEO?

The filing shows 23,515 Analog Devices common shares held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. These trust-held shares are reported as indirect ownership, separate from Roche’s directly owned shares.